Adam leads Northpond’s work in life science R&D solutions, molecular diagnostics, and environmental sciences. In addition to his position on Encodia’s board, he is also a board director at several other private and public diagnostics, tools, and environmental sciences companies. Previously, he was a vice president at Cowen and Company, where he covered the life science tools and diagnostics space for six years. Prior to Cowen, he conducted his postdoctoral studies at Tufts Medical School, where he developed and refined drug candidates across several therapeutic areas.

Adam holds a Ph.D. from the University of Illinois College of Medicine, a B.S. in biochemistry and molecular biology from University of Georgia, and he is a CFA charterholder.